Your first month on compounded semaglutide is mostly about your body adjusting. Not about dramatic weight loss. Not about life-changing transformations. It’s a calibration period—and understanding that from the start will save you from frustration and help you stick with it.
Here’s what the first four weeks actually look like for most people, based on clinical data from the STEP trials and real-world provider observations.
Before You Start: What You Should Have Ready
- Your injection supplies: Vial, syringes, alcohol swabs, sharps container. Your provider should send these or instruct you on what to order.
- Refrigerator space: Your vial needs to be stored at 36–46°F (2–8°C) on a middle shelf, not the door.
- A food journal or tracking app: Not to obsess over calories, but to notice patterns in appetite and tolerance as the medication takes effect.
- Protein-rich foods stocked: Your appetite will shrink. When you eat less, the quality of what you eat matters more. Aim for 25–30g protein per meal from day one.
- Anti-nausea supplies: Ginger chews, peppermint tea, small bland snacks (crackers, toast). Many people don’t need these, but having them on hand prevents a miserable first few days if you do.
The Introduction — 0.25mg Dose
Your first injection is a starter dose of 0.25mg—intentionally low. This dose is not therapeutic for weight loss. Its purpose is to let your GLP-1 receptors adjust gradually and minimize side effects.
What most people experience:
- Mild appetite reduction: You might notice you’re slightly less hungry, or you feel full sooner at meals. Some people feel nothing yet. Both are normal.
- Possible nausea: The most common side effect. Usually mild and manageable. Tends to appear a few hours after injection and may come and go for 1–2 days.
- Fatigue: Some people feel more tired than usual, partly from eating less and partly from the medication itself.
- No significant weight change: You might see 1–2 pounds of water-weight fluctuation, but don’t expect meaningful fat loss this early.
What to do: Eat smaller, more frequent meals. Stay hydrated (aim for 64+ oz of water daily). Take your injection at the same time each week. If nausea hits, eat bland foods and avoid lying down right after meals.
Settling In — Still 0.25mg
By your second injection, your body is starting to build steady-state blood levels of semaglutide. The half-life is about one week, so each injection builds on the previous one.
What most people experience:
- More noticeable appetite suppression: The “food noise”—that constant background chatter about what to eat next—starts to quiet for many people. This is often described as the most immediately noticeable effect.
- Side effects stabilizing: If you had nausea in week 1, it often improves by week 2 as your body adjusts. If you didn’t have nausea yet, you probably won’t at this dose.
- Possible constipation: GLP-1 medications slow gastric emptying. Less food in plus slower digestion can mean fewer bowel movements. Increase fiber and water intake.
- Modest weight change: Some people see 2–4 pounds down, mostly from reduced food intake and water shifts. Others see nothing. Neither predicts your long-term outcome.
What to do: Don’t weigh yourself daily. Weekly weigh-ins at the same time (morning, after bathroom, before food) give much more useful data. Focus on protein intake—30g per meal minimum.
Building Momentum — Still 0.25mg
By week 3, semaglutide is approaching steady-state concentration in your body. Most early side effects have either resolved or become predictable and manageable.
What most people experience:
- Consistent appetite reduction: Meals are smaller without effort. You may forget to eat, which is actually a risk—skipping meals entirely can lead to nutrient deficiencies and muscle loss.
- Changed relationship with food: Social eating, stress eating, and boredom eating may feel different. The compulsion is reduced, but the habit may persist. This is where behavioral awareness matters.
- Energy levels normalizing: Any fatigue from weeks 1–2 usually improves as your body adapts to lower caloric intake.
- Some measurable weight loss: Clinical data from STEP trials shows weight loss becomes statistically significant by week 4, though individual variation is wide.
What to do: Don’t skip meals. Eat scheduled protein-forward meals even if you’re not hungry. Start or continue resistance exercise to protect lean muscle mass. This is the most important lifestyle factor alongside the medication.
First Dose Increase — Titrating to 0.5mg
Most protocols increase your dose to 0.5mg at the 4-week mark. This is where the therapeutic dose escalation begins.
What most people experience:
- Temporary return of side effects: Nausea, digestive changes, or fatigue may briefly return at the new dose level. This typically subsides within 3–5 days.
- Stronger appetite suppression: The jump from 0.25mg to 0.5mg is often when people notice the most significant change in hunger and food noise.
- Measurable weight loss: Most people see 3–6 pounds lost by the end of month one. This is a combination of reduced food intake and early metabolic changes.
- Clothes fitting differently: Even before the scale moves dramatically, many people notice their clothes feeling looser, particularly around the midsection.
What to do: If side effects at 0.5mg are severe, contact your provider. They may delay the dose increase or add supportive measures. Do not adjust your dose independently.
What’s Normal vs. When to Call Your Provider
Setting Realistic Expectations
Social media has distorted expectations for GLP-1 medications. Here’s what the clinical data actually shows:
- Month 1: Average weight loss of 2–5% of body weight. Some people lose more, some less. Early weight loss includes water and glycogen, not just fat.
- Months 2–4: The steepest weight loss curve. Most of your total loss occurs in this window as you titrate to therapeutic doses (1.0–2.4mg).
- Months 6–12: Weight loss begins to plateau as your body reaches a new equilibrium. This is normal biology, not treatment failure.
- Average total loss: The STEP 1 trial showed ~15% of body weight lost over 68 weeks with semaglutide 2.4mg. SURMOUNT-1 showed ~21% with tirzepatide at the highest dose.
The first month is laying groundwork. If you’re not seeing dramatic results at week 2 or 3, that does not mean the medication isn’t working. The titration schedule exists for a reason—it prioritizes tolerability and long-term adherence over speed.
Ready to Get Started?
Compare vetted providers offering compounded semaglutide with proper dose titration protocols.
Compare Providers →Five Things to Do (and Not Do) in Month One
Do
- Prioritize protein at every meal (30g minimum). Your appetite will shrink—make every bite count for muscle preservation.
- Stay hydrated. GLP-1 medications slow gastric emptying, and reduced food intake means less water from food. Aim for 64–80oz daily.
- Start or continue resistance training. Weight loss without resistance exercise risks significant lean mass loss. Even 2–3 sessions per week makes a measurable difference.
- Track your weekly weight trend, not daily fluctuations. A spreadsheet or app that shows the trend line is far more useful than any single number.
- Communicate with your provider. Report side effects, ask about dose timing, and don’t wait until things are severe to reach out.
Don’t
- Don’t skip meals entirely because you’re not hungry. Under-eating leads to muscle loss, nutrient deficiency, and eventual metabolic adaptation.
- Don’t compare yourself to social media. The person who “lost 20 pounds in month one” either had a very different starting point, is exaggerating, or is losing a concerning amount of lean mass.
- Don’t adjust your dose without provider guidance. More is not better. Faster titration leads to worse side effects and higher dropout rates.
- Don’t drink alcohol excessively. GLP-1 medications can change your alcohol tolerance unpredictably. Start slow and pay attention to how you feel.
- Don’t stop the medication abruptly without discussing it with your provider. Sudden discontinuation can cause appetite rebound.